Legal & General Group PLC Pa Vmed Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.57 - $34.65 $3,271 - $198,856	-5,739 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.85 - $1.41 $1,479 - $2,454	-1,741 Reduced 23.28%	5,739 $5,000
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $892 - $1,643	-175 Reduced 2.29%	7,480 $64,000
Q2 2021 Aug 12, 2021	BUY	$3.95 - $6.88 $3,614 - $6,295	915 Added 13.58%	7,655 $49,000
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $4,932 - $13,619	2,454 Added 57.26%	6,740 $30,000
Q3 2020 Nov 13, 2020	SELL	$1.76 - $2.17 $2,808 - $3,463	-1,596 Reduced 27.13%	4,286 $8,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.65 $10,293 - $15,587	5,882 New	5,882 $12,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $106M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.